Happenings

08 Jan 2026

MULTISPECIALITY JOURNAL CLUB

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial Presenter:- Dr. Gaurav Ojha, Resident

701